补肾活血方定向透药治疗肾虚血瘀型绝经后骨质疏松症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R274.9;R681

基金项目:

余姚市科技计划项目(2024YZPT03)


Clinical Study on Targeted Transdermal Delivery of Bushen Huoxue Prescription for Postmenopausal Osteoporosis of Kidney Deficiency and Blood Stasis Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于肾藏精主骨理论探讨补肾活血方定向透药治疗对肾虚血瘀型绝经后骨质疏松症患者的治疗效果。方法:选取2024年3月—2025年2月余姚市中医医院收治的肾虚血瘀型绝经后骨质疏松症患者60例,按随机数字表法分为对照组与观察组各30例。对照组给予西药常规治疗,观察组在对照组的基础上加用补肾活血方定向透药治疗。2组疗程均为3个月。比较2组临床疗效,以及治疗前后中医证候评分、疼痛改善情况[视觉模拟评分法(VAS)] 及骨代谢指标[血清钙(Ca)、磷(P)、骨碱性磷酸酶(BAP)] 水平。结果:治疗后,观察组总有效率为93.33% (28/30),对照组为73.33% (22/30),2组比较,差异有统计学意义(P<0.05)。治疗后,2组腰背及周身疼痛、痛有定处、痛处拒按、筋肉挛缩等中医证候评分均较治疗前降低(P<0.05),且观察组各项评分均低于对照组(P<0.05)。治疗后1周、2周、3个月后,2组疼痛VAS评分均较治疗前降低(P<0.05),且观察组相同时间点评分均低于对照组(P<0.05)。治疗后,2组血清Ca、P、BAP水平均治疗前升高(P<0.05),且观察组Ca、P、BAP水平均高于对照组(P<0.05)。结论:基于肾藏精主骨理论给予补肾活血方定向透药治疗肾虚血瘀型绝经后骨质疏松症,可提高临床疗效,显著改善患者疼痛症状及骨代谢水平。

    Abstract:

    Abstract: Objective: To investigate the therapeutic effect of targeted transdermal delivery of Bushen Huoxue Prescription on postmenopausal osteoporosis of kidney deficiency and blood stasis type under the guidance of the theory of the kidney stores essence and governs the bones. Methods:A total of 60 patients with postmenopausal osteoporosis of kidney deficiency and blood stasis type admitted to Yuyao Hospital of Traditional Chinese Medicine from March 2024 to February 2025 were enrolled. They were randomly divided into the control group and the observation group using the random number table method, with 30 cases in each group. The control group received conventional western medicine treatment , while the observation group received targeted transdermal delivery of Bushen Huoxue Prescription in addition to the treatment of the control group. The course of treatment was three months for both groups. The clinical efficacy, traditional Chinese medicine syndrome scores, pain improvement [assessed by Visual Analogue Scale (VAS)], and bone metabolism markers [serum calcium (Ca), phosphorus (P), bone alkaline phosphatase (BAP)] were compared between the two groups before and after treatment. Results:After treatment,the total effective rate was 93.33% (28/30) in the observation group and 73.33% (22/30) in the control group, with a statistically significant difference between the two groups (P<0.05). After treatment,the traditional Chinese medicine syndrome scores for low back and general pain,pain of fixed location,pain that is intolerable to pressure,and muscle spasm decreased in both groups compared with those before treatment (P<0.05), and all scores in the observation group were lower than those in the control group (P<0.05). At one week, two weeks, and three months after the treatment,the VAS scores in both groups decreased compared with those before treatment (P<0.05),and the scores in the observation group were lower than those in the control group at the same time points (P<0.05). After treatment, serum levels of Ca,P,and BAP in both groups increased compared with those before treatment (P<0.05),and the levels of Ca,P,and BAP in the observation group were higher than those in the control group (P<0.05). Conclusion: Treatment with targeted transdermal delivery of Bushen Huoxue Prescription for postmenopausal osteoporosis of kidney deficiency and blood stasis type,based on the theory that the kidney storing essence and governing bones,can improve clinical efficacy,significantly relieve pain,and enhance bone metabolism.

    参考文献
    相似文献
    引证文献
引用本文

顾佩娜,黄金波,吴闻洁.补肾活血方定向透药治疗肾虚血瘀型绝经后骨质疏松症临床研究[J].新中医,2026,58(18):32-36

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-09-29
  • 出版日期:
文章二维码